EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Bronchoalveolar lavage fluid analysis in patients with checkpoint inhibitor pneumonitis

Ruxuan Chen, Yujie Shi, Nan Fang, Chi Shao, Hui Huang, Ruili Pan, Yan Xu, Mengqi Wang, Xiangning Liu, Kai Xu, Rui Zhu, Mengzhao Wang

Cancer Immunology, Immunotherapy · 2024

DOI: 10.1007/s00262-024-03834-y ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Immunology, Immunotherapy, 2024. Verfasst von Ruxuan Chen und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary and Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical…. Hauptthemen laut MEDLINE: Immune Checkpoint Inhibitors, Bronchoalveolar Lavage Fluid, Pneumonia. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National High Level Hospital Clinical Research Funding.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Checkpoint inhibitor pneumonitis (CIP) is a relatively uncommon but potentially life-threatening immune-related adverse event (irAE). Lung biopsies have not been commonly performed for CIP patients. Bronchoalveolar lavage fluid (BALF) analysis is a useful diagnostic approach for interstitial lung disease. However, BALF features were inconsistent across different studies. METHODS: We retrospectively reviewed the medical records of 154 patients with pathologically confirmed malignancies and suffering from CIPs between July 2018 and December 2022. Patients who had bronchoalveolar lavage (BAL) data available were enrolled in our study. Patient clinical, laboratory, radiological and follow-up data were reviewed and analyzed. RESULTS: The BALF differential cell count and lymphocyte subset analysis were performed for 42 CIP patients. There were 32 males (76.2%). The mean age at diagnosis of CIP was 62.0 ± 10.4 (range: 31-78) years. The median time to onset of CIP was 98.5 days after the start of immunotherapy. There were 18 patients (42.9%) with low-grade CIPs and 24 patients (57.1%) with high-grade CIPs. The mean lymphocyte percentage was 36.7 ± 22.5%. There were 34 (81%) CIP patients with a lymphocytic cellular pattern. The median ratio of CD3+CD4+/CD3+CD8+ lymphocytes was 0.5 (0.3, 1.0). The ratio was less than 1.0 for 31 CIP patients (73.8%). However, there was no significant difference in the BALF features between patients with low-grade CIPs and those with high-grade CIPs. CONCLUSIONS: The CD3+CD8+ lymphocytosis pattern was the main inflammatory profile in the BALF of CIP patients in this cohort. Targeting CD3+CD8+ lymphocytes might be a treatment option for CIPs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immune Checkpoint InhibitorsBronchoalveolar Lavage FluidPneumoniaHumansMaleFemaleMiddle AgedAgedRetrospective StudiesAdultNeoplasms

Stichwörter der Autor:innen

Bronchoalveolar lavage fluidCheckpoint inhibitor pneumonitisImmune-related adverse eventLymphocyte subset analysis

Substanzen

Immune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Department of Pulmonary and Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, #1 Shuaifuyuan Street, Dongcheng District, Beijing, 100730,…
  • State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, #1 Xian Nong Tan Street, Beijing, 100050,…
  • Department of Internal Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, #1 Shuaifuyuan Street, Dongcheng District, Beijing, 100730, China.
  • Department of Radiology, Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, #1 Shuaifuyuan Street, Dongcheng District, PekingBeijing, 100730, China.
  • Department of Medical Records, Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, #1 Shuaifuyuan Street, Dongcheng District, PekingBeijing, 100730, China.

Förderung

  • National High Level Hospital Clinical Research Funding

Zitieren

APA

Chen, R., Shi, Y., Fang, N., Shao, C., Huang, H., Pan, R., Xu, Y., Wang, M., Liu, X., Xu, K., Zhu, R., & Wang, M. (2024). Bronchoalveolar lavage fluid analysis in patients with checkpoint inhibitor pneumonitis. Cancer Immunology, Immunotherapy. https://doi.org/10.1007/s00262-024-03834-y

Vancouver

Chen R, Shi Y, Fang N, Shao C, Huang H, Pan R, et al. Bronchoalveolar lavage fluid analysis in patients with checkpoint inhibitor pneumonitis. Cancer Immunology, Immunotherapy. 2024. doi:10.1007/s00262-024-03834-y

BibTeX
@article{Chen2024,
  author = {Chen, Ruxuan and Shi, Yujie and Fang, Nan and Shao, Chi and Huang, Hui and Pan, Ruili and Xu, Yan and Wang, Mengqi and Liu, Xiangning and Xu, Kai and Zhu, Rui and Wang, Mengzhao},
  title = {Bronchoalveolar lavage fluid analysis in patients with checkpoint inhibitor pneumonitis},
  journal = {Cancer Immunology, Immunotherapy},
  year = {2024},
  doi = {10.1007/s00262-024-03834-y}
}
Kostenlos starten →